scholarly journals Associations of pre-existing co-morbidities with skeletal muscle mass and radiodensity in patients with non-metastatic colorectal cancer

2018 ◽  
Vol 9 (4) ◽  
pp. 654-663 ◽  
Author(s):  
Jingjie Xiao ◽  
Bette J. Caan ◽  
Erin Weltzien ◽  
Elizabeth M. Cespedes Feliciano ◽  
Candyce H. Kroenke ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Skeletal Muscle ◽  
Metastatic Colorectal Cancer ◽  
Muscle Mass ◽  
Skeletal Muscle Mass

scholarly journals Impact of different palliative systemic treatments on skeletal muscle mass in metastatic colorectal cancer patients

2018 ◽  
Vol 9 (5) ◽  
pp. 909-919 ◽  
Author(s):  
Sophie A. Kurk ◽  
Petra H.M. Peeters ◽  
Bram Dorresteijn ◽  
Pim A. de Jong ◽  
Marion Jourdan ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Skeletal Muscle ◽  
Metastatic Colorectal Cancer ◽  
Cancer Patients ◽  
Muscle Mass ◽  
Skeletal Muscle Mass ◽  
Systemic Treatments ◽  
Colorectal Cancer Patients

scholarly journals Skeletal muscle mass loss and dose‐limiting toxicities in metastatic colorectal cancer patients

2019 ◽  
Vol 10 (4) ◽  
pp. 803-813 ◽  
Author(s):  
Sophie Kurk ◽  
Petra Peeters ◽  
Rebecca Stellato ◽  
B. Dorresteijn ◽  
Pim Jong ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Skeletal Muscle ◽  
Mass Loss ◽  
Metastatic Colorectal Cancer ◽  
Cancer Patients ◽  
Muscle Mass ◽  
Skeletal Muscle Mass ◽  
Muscle Mass Loss ◽  
Colorectal Cancer Patients

scholarly journals No evidence for changes in skeletal muscle mass or weight during first-line chemotherapy for metastatic colorectal cancer

BMC Cancer ◽  
2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Sami Antoun ◽  
Mohamed Amine Bayar ◽  
Valérie Dyevre ◽  
Emilie Lanoy ◽  
Cristina Smolenschi ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Skeletal Muscle ◽  
Metastatic Colorectal Cancer ◽  
Muscle Mass ◽  
Skeletal Muscle Mass ◽  
First Line ◽  
Line Chemotherapy

Low Skeletal Muscle Mass before Salvage-Line Chemotherapy Is a Poor Prognostic Factor in Patients with Refractory Metastatic Colorectal Cancer

Digestion ◽  
2018 ◽  
Vol 99 (1) ◽  
pp. 79-85 ◽  
Author(s):  
Yuji Miyamoto ◽  
Yukiharu Hiyoshi ◽  
Takahiko Akiyama ◽  
Yuki Kiyozumi ◽  
Kojiro Eto ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Skeletal Muscle ◽  
Prognostic Factor ◽  
Metastatic Colorectal Cancer ◽  
Muscle Mass ◽  
Skeletal Muscle Mass ◽  
Poor Prognostic Factor ◽  
Line Chemotherapy

scholarly journals Low skeletal muscle mass as a risk factor for postoperative delirium in elderly patients undergoing colorectal cancer surgery

2018 ◽  
Vol Volume 13 ◽  
pp. 2097-2106 ◽  
Author(s):  
Christina Alexa Mosk ◽  
Jeroen LA van Vugt ◽  
Huub de Jonge ◽  
Carlijn Witjes ◽  
Stefan Buettner ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Skeletal Muscle ◽  
Risk Factor ◽  
Elderly Patients ◽  
Muscle Mass ◽  
Skeletal Muscle Mass ◽  
Postoperative Delirium ◽  
Cancer Surgery ◽  
Colorectal Cancer Surgery

scholarly journals Longitudinal Changes in CT Body Composition in Patients Undergoing Surgery for Colorectal Cancer and Associations With Peri-Operative Clinicopathological Characteristics

2021 ◽  
Vol 8 ◽  
Author(s):  
Ross D. Dolan ◽  
Tanvir Abbass ◽  
Wei M. J. Sim ◽  
Arwa S. Almasaudi ◽  
Ly B. Dieu ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Skeletal Muscle ◽  
Body Composition ◽  
Inflammatory Response ◽  
Muscle Mass ◽  
Skeletal Muscle Mass ◽  
Systemic Inflammatory Response ◽  
Ct Scans ◽  
Lower Percentage

There is evidence for the direct association between body composition, the magnitude of the systemic inflammatory response, and outcomes in patients with colorectal cancer. Patients with a primary operable disease with and without follow-up CT scans were examined in this study. CT scans were used to define the presence and changes in subcutaneous fat, visceral fat, skeletal muscle mass, and skeletal muscle density (SMD). In total, 804 patients had follow-up scans and 83 patients did not. Furthermore, 783 (97%) patients with follow-up scans and 60 (72%) patients without follow-up scans were alive at 1 year. Patients with follow-up scans were younger (p < 0.001), had a lower American Society of Anaesthesiology Grade (p < 0.01), underwent a laparoscopic surgery (p < 0.05), had a higher BMI (p < 0.05), a higher skeletal muscle index (SMI) (p < 0.01), a higher SMD (p < 0.01), and a better 1-year survival (p < 0.001). Overall only 20% of the patients showed changes in their SMI (n = 161) and an even lower percentage of patients showed relative changes of 10% (n = 82) or more. In conclusion, over the period of ~12 months, a low–skeletal muscle mass was associated with a systemic inflammatory response and was largely maintained following surgical resection.

Sign in / Sign up

Export Citation Format

Share Document